Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin

Direct-acting antivirals (DAAs) are relatively safe and highly effective for the eradication of hepatitis C virus (HCV) in liver transplant recipients. In this case study, we present a female with a graft reinfected with HCV genotype 2 who was treated with a combination of sofosbuvir and ribavirin a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Case Rep Gastroenterol
Huvudupphovsmän: Sasaki, Reina, Kanda, Tatsuo, Ohtsuka, Masayuki, Yasui, Shin, Haga, Yuki, Nakamura, Masato, Yokoyama, Masayuki, Wu, Shuang, Nakamoto, Shingo, Arai, Makoto, Maruyama, Hitoshi, Miyazaki, Masaru, Yokosuka, Osamu
Materialtyp: Artigo
Språk:Inglês
Publicerad: S. Karger AG 2016
Ämnen:
Single Case
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5043295/
https://ncbi.nlm.nih.gov/pubmed/27721720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000447423
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk